Cargando…

Risk Stratification and Clinical Utility of Polygenic Risk Scores in Ophthalmology

Combining genetic and clinical data into an informative risk prediction profile has been an important ambition of personalized medicine. Single-nucleotide polymorphisms are commonly found throughout the genome and account for the majority of interindividual genetic variation. To date, genome-wide as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qassim, Ayub, Souzeau, Emmanuelle, Hollitt, Georgie, Hassall, Mark M., Siggs, Owen M., Craig, Jamie E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Association for Research in Vision and Ophthalmology 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114010/ https://www.ncbi.nlm.nih.gov/pubmed/34111261 http://dx.doi.org/10.1167/tvst.10.6.14

Ejemplares similares

Genetic Risk Assessment of Degenerative Eye Disease (GRADE): study protocol of a prospective assessment of polygenic risk scores to predict diagnosis of glaucoma and age-related macular degeneration
por: Hollitt, Georgina L, et al.
Publicado: (2023)

Normal-tension glaucoma is associated with cognitive impairment
por: Mullany, Sean, et al.
Publicado: (2022)

Autosomal dominant nanophthalmos and high hyperopia associated with a C-terminal frameshift variant in MYRF
por: Siggs, Owen M., et al.
Publicado: (2019)

Attitudes Toward Glaucoma Genetic Risk Assessment in Unaffected Individuals
por: Hollitt, Georgina L., et al.
Publicado: (2022)

Performance of polygenic risk scores in screening, prediction, and risk stratification: secondary analysis of data in the Polygenic Score Catalog
por: Hingorani, Aroon D, et al.
Publicado: (2023)

Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores
por: de Rojas, Itziar, et al.
Publicado: (2021)

Phenotypic consequences of a nanophthalmos-associated TMEM98 variant in human and mouse
por: Hassall, Mark M., et al.
Publicado: (2023)

Evaluating the prognostic performance of a polygenic risk score for breast cancer risk stratification
por: Olsen, Maria, et al.
Publicado: (2021)

Author Correction: Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores
por: de Rojas, Itziar, et al.
Publicado: (2023)

On the utilization of polygenic risk scores for therapeutic targeting
por: Gibson, Greg
Publicado: (2019)

A Breast Cancer Polygenic Risk Score Is Feasible for Risk Stratification in the Norwegian Population
por: Akdeniz, Bayram Cevdet, et al.
Publicado: (2023)

Risk Stratification for Bipolar Disorder Using Polygenic Risk Scores Among Young High-Risk Adults
por: Biere, Silvia, et al.
Publicado: (2020)

Large uncertainty in individual polygenic risk score estimation impacts PRS-based risk stratification
por: Ding, Yi, et al.
Publicado: (2022)

A polygenic risk score for nasopharyngeal carcinoma shows potential for risk stratification and personalized screening
por: He, Yong-Qiao, et al.
Publicado: (2022)

Post‐GWAS Polygenic Risk Score: Utility and Challenges
por: Nguyen, Tuan V, et al.
Publicado: (2020)

Genetically-regulated pathway-polygenic risk score (GRPa-PRS): A risk stratification method to identify genetically regulated pathways in polygenic diseases
por: Li, Xiaoyang, et al.
Publicado: (2023)

Prostate cancer risk stratification improvement across multiple ancestries with new polygenic hazard score
por: Huynh-Le, Minh-Phuong, et al.
Publicado: (2022)

The clinical utility of polygenic risk scores for chronic lymphocytic leukemia
por: Sud, Amit, et al.
Publicado: (2021)

Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores
por: Bianco, Cristiana, et al.
Publicado: (2021)

Demographic history mediates the effect of stratification on polygenic scores
por: Zaidi, Arslan A, et al.
Publicado: (2020)

Risk stratification for hepatocellular cancer among patients with cirrhosis using a hepatic fat polygenic risk score
por: Thrift, Aaron P., et al.
Publicado: (2023)

Improving the Utility of Polygenic Risk Scores as a Biomarker for Alzheimer’s Disease
por: Vlachakis, Dimitrios, et al.
Publicado: (2021)

Clinical utility of polygenic risk scores: a critical 2023 appraisal
por: Koch, Sebastian, et al.
Publicado: (2023)

The False Dawn of Polygenic Risk Scores for Human Disease Prediction
por: Herzig, Anthony F., et al.
Publicado: (2022)

PRSice: Polygenic Risk Score software
por: Euesden, Jack, et al.
Publicado: (2015)

Genetic Risk of Cardiovascular Disease Is Associated with Macular Ganglion Cell–Inner Plexiform Layer Thinning in an Early Glaucoma Cohort
por: Marshall, Henry, et al.
Publicado: (2021)

Polygenic Risk Scores and Physical Activity
por: KUJALA, URHO M., et al.
Publicado: (2020)

Polygenic transcriptome risk scores (PTRS) can improve portability of polygenic risk scores across ancestries
por: Liang, Yanyu, et al.
Publicado: (2022)

The Polygenic Risk Score Knowledge Base offers a centralized online repository for calculating and contextualizing polygenic risk scores
por: Page, Madeline L., et al.
Publicado: (2022)

RNA Sequencing of Lens Capsular Epithelium Implicates Novel Pathways in Pseudoexfoliation Syndrome
por: Mullany, Sean, et al.
Publicado: (2022)

OR32-02 Thyroid Cancer Polygenic Risk Score Improves Risk Stratification Of Thyroid Nodules When Added To Ultrasound Imaging
por: Pozdeyev, Nikita, et al.
Publicado: (2023)

Utility of Polygenic Risk Scoring to Predict Cognitive Impairment as Measured by Preclinical Alzheimer Cognitive Composite Score
por: Gao, Q., et al.
Publicado: (2022)

Comparison of Anterior Segment Abnormalities in Individuals With FOXC1 and PITX2 Variants
por: Prem Senthil, Mallika, et al.
Publicado: (2022)

Patient and provider perspectives on polygenic risk scores: implications for clinical reporting and utilization
por: Lewis, Anna C. F., et al.
Publicado: (2022)

Evaluating the Utility of Polygenic Risk Scores in Identifying High-Risk Individuals for Eight Common Cancers
por: Jia, Guochong, et al.
Publicado: (2020)

Polygenic Risk Scores for Subtyping of Schizophrenia
por: Chen, Jingchun, et al.
Publicado: (2020)

Polygenic risk scores and rheumatic diseases
por: Brown, Matthew A., et al.
Publicado: (2021)

Polygenic Risk Score Prediction for Endometriosis
por: Kloeve-Mogensen, Kirstine, et al.
Publicado: (2021)

Prospects for using risk scores in polygenic medicine
por: Lewis, Cathryn M., et al.
Publicado: (2017)

Polygenic risk scores in psychiatry: Will they be useful for clinicians?
por: Fullerton, Janice M., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5rhk6sj3lmec0v9qsngrsmesnp